| 摘要 |
The present invention provides stable encapsulated (-)-hydroxycitric acid ("HCA")~containing compositions and methods of making the same. A method is provided by which the hygroscopic salts of HCA in their relatively pure and active forms, including especially the potassium salt, but also including th e sodium salt, are rendered non-hygroscopic and stable (that is, not prone to lactonization, not readily subject to attachment to ligands which inhibit absorption or lead to excretion, and so forth) such that these HCA salts mig ht be included in dry delivery formats, liquid delivery and in controlled-relea se vehicles. The nonhygroscopic salts of HCA and its derivatives likewise may b e protected against acid degradation, lactonization and undesirable ligand binding when exposed to acidic environments or other challenging conditions. The method taught herein can be employed to reduce the polar/ionic qualities of HCA salts and derivatives when presented to the intestinal lumen to provi de advantages in absorption.
|
